Our research provides insights into an unreported molecular mechanism of the lncRNA ZFAS1 in the regulation of CRC initiation and pathogenesis, which provide novel potential biomarkers and therapeutic targets for CRC treatment and prognostic evaluation. Here, ZFAS1 is linked to colorectal carcinoma.